New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous - oral solution - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: carmellose sodium cherry extract fache 5913g methyl hydroxybenzoate propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - xylocaine viscous solution is indicated for the relief of pain and discomfort associated with: · irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome · introduction of instruments and catheters into the respiratory and gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - lignocaine hydrochloride anhydrous; adrenaline acid tartrate; lignocaine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - lignocaine hydrochloride anhydrous; adrenaline acid tartrate; lignocaine hydrochloride -

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - lidocaine - ointment - 50 mg/g - lidocaine 5g/100g

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine, quantity: 100 mg/ml - spray, solution - excipient ingredients: ethanol; menthol; purified water; macrogol 400; saccharin; flavour - xylocaine 10% pump spray is used for surface anaesthesia of the mucous membranes prior to the following procedures:,otorhinolaryngology:,to prepare for puncture of the maxillary sinus; for analgesia of the pharynx to prevent gagging and stress reactions when inserting instruments.,dental practice:,before injections, treating minor abscesses, suture removal, deep scaling and to prevent gagging when taking intraoral impressions and x-rays.,general anaesthesia:,to prevent coughing with an endotracheal tube in situ during light surgical anaesthesia.,obstetrics:,during the final stages of delivery and before episiotomy and perineal suturing as supplementary pain control.

United States - English - NLM (National Library of Medicine)

cardinal health - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - lidocaine hydrochloride; adrenaline (epinephrine) tartrate - solution for injection - 2 percent weight/volume - amides; prilocaine

United States - English - NLM (National Library of Medicine)

dentsply pharmaceutical - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - 2% xylocaine dental solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques. only accepted procedures for these techniques as described in standard textbooks are recommended. 2% xylocaine dental is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply (australia) pty ltd - lignocaine hydrochloride; adrenaline acid tartrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline;  ; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline   lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - the product is indicated for the production of local nerve anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.